Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Clinical Drug Investigation|April 9, 2014
Availability of data on adverse reactions to antiretroviral drugs in medical charts according to the Naranjo algorithm: an example of a Brazilian historical cohortCristiane A Menezes de Pádua, Cristiano S Moura
International Journal of Rheumatic Diseases|April 18, 2019
Care quality for rheumatoid arthritis patients in QuebecZeinab Slim, Cristiano S Moura, Sasha Bernatsky, et al.
Pharmacoepidemiology and Drug Safety|August 2, 2023
Importance of accounting for timing of time-varying exposures in association studies: Hydrochlorothiazide and non-melanoma skin cancerCoraline Danieli, Cristiano S Moura, Louise Pilote, et al.
International Journal of Clinical Pharmacy|April 27, 2012
Evaluation of drug-drug interaction screening software combined with pharmacist interventionCristiano S Moura, Nília M Prado, Najara O Belo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 12, 2015
Opioid Use and Risk of Nonvertebral Fractures in Adults With Rheumatoid Arthritis: A Nested Case-Control Study Using Administrative DatabasesFrancisco A Acurcio, Cristiano S Moura, Sasha Bernatsky, et al.
Pregnancy Hypertension|September 6, 2019
Peripartum cardiomyopathy with co-incident preeclampsia: A cohort study of clinical risk factors and outcomes among commercially insured womenIsabelle Malhamé, Natalie Dayan, Cristiano S Moura, et al.
Chronic Illness|January 11, 2021
Agreement in the CARTaGENE cohort between self-reported medication use and claim dataCristiano S Moura, Yves Payette, Catherine Boileau, et al.
Journal of Diabetes Research|May 2, 2018
Treatment Discontinuation and Clinical Events in Type 2 Diabetes Patients Treated with Dipeptidyl Peptidase-4 Inhibitors or NPH Insulin as Third-Line TherapyCristiano S Moura, Zale B Rosenberg, Michal Abrahamowicz, et al.
Journal of the American Heart Association|January 7, 2020
Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes MellitusValeria Raparelli, Malik Elharram, Cristiano S Moura, et al.
International Journal of Cardiology|April 19, 2020
Novel glucose lowering agents are associated with a lower risk of cardiovascular and adverse events in type 2 diabetes: A population based analysisMalik Elharram, Cristiano S Moura, Michal Abrahamowicz, et al.
Pageof 3